Categories
- Features
- Foreign News
- General Practice
- Health Management
- Hospital Medicine
- Industrial Relations
- Information Technology
- Interviews
- Medico-Legal
- News
- Obituary
- Planning and Development
- Private Healthcare
- Public Health
- Regulation
- Research and Education
Archives
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- February 2007
Tagcloud
abortion, abuse, acute care, addiction, administration, alcohol, alternative medicine, arthritis, autoimmune disorders, blood, breast cancer, Brendan Drumm, cancer, capacity, cardiovascular disease, casemix, CervicalCheck, charity, children, clinical directors, clinical indemnity scheme, co-location, co-ops, community care, competence assurance, Competition Authority, complaints, consultants, cosmetic surgery, costs, cross-border, cutbacks, cystic fibrosis, Department of Health, diabetes, disability, Down's syndrome, drugs, e-health, education, elderly, emergency medicine, epilepsy, equity, ESRI, ethics, EWTD, fertility, Fitness to Practice, fractures, funding, General Election, genetics, GP Survey, GPs, Hanly report, HIQA, HIV, HPSC, HRB, hse, HSE, human tissue, hygiene, hypertension, IBTS, ICGP, IHCA, IMB, immunity, imo, IMO, industrial action, influenza, INO, insurance, Irish Healthcare Awards, IT, locums, LRC, lung disease, maternity, MAUs, media, medical cards, Medical Council, medical school, medico-legal, men's health, mental health, migraine, MRSA, NCHDs, needle-stick injury, neurology, NHS, Non-EU doctors, North East, NTPF, nurses, nursing home, nutrition, obesity, obstetrics, Ombudsman, out-of-hours, palliative care, pandemic, patient records, PCRS (GMS), pharmaceuticals, pharmacy, politics, practice management, pregnancy, prescribing, primary care, privatisation, quality, radiology, radiotherapy, RCPI, RCSI, reconfiguration, recruitment, regional hospitals, renal, research, savings, screening, sexual assault, sexual health, smoking, sports medicine, stem cells, stroke, suicide, surgery, transplants, transport, tuberculosis, vaccine, Vhi, waiting lists, WHO, women's health, work-life balance
«Previous article | Next article»
Sanofi Pasteur, maker of Gardasil, wins contract to supply cervical cancer vaccine in Ireland
The contract to supply a cervical cancer vaccine which has been awarded to Sanofi Pasteur, the Minister for Health, Mary Harney, confirmed at yesterday’s meeting of the Joint Oireachtas Committee on Health.
The vaccine, Gardasil, will be given to first-year students in second-level schools this year.
Gardasil protects against the HPV virus and also against genital warts. The announcement follows a two-week “cooling off” period after the contract was awarded.
Gardasil is the only cervical cancer vaccine that helps protect against four types of human papillomavirus (HPV): two types that cause 70 per cent of cervical cancer cases, and two more types that cause 90 per cent of genital warts cases.
Gardasil is aimed at girls and young women aged nine to 26.
Gardasil may not fully protect everyone, and does not prevent all types of cervical cancer, so it’s important to continue routine cervical cancer screenings, according to Gardasil.com. It is given as three injections over six months.
Posted in Public Health on 10 February 2010
Tags: cancer, vaccine
Comments
Ireland - beware- There are now more than 19,000 adverse reactions and 60 deaths reported to VAERS (between 1 to 10% reporting. According to Diane Harper, the lead researcher on this vaccine for Merck and who backed away from the project "there are now more adverse reactions than there are cases of cervical cancer. Parents across the world are coming together, sharing stories, documents and research on the adverse reactions to share with their respective governments. Please educate yourself about this vaccine before your daughter becomes "one less" healthy teenager.
Posted by: Leslie on Friday 12 February 2010
More articles from IMT News
I'm jealous! I'm a consultant in sexual health in the UK. The UK DoH took a shortsighted financial view and chose Cervarix - which does not also prtoect against genital warts. In countries like Australia where Gardasil has been the vaccine of choice they have already seen a 48% reduction in new cases of genital warts in young women. They will have eradicated genital warts and mild dyskaryosis from HPV 6 and 11 within a few years. As the UK is one of the few countries to have chosen the 'wrong' vaccine Australian doctors were saying that the biggest threat to them is now British backpackers continuing to bring in HPV 6 and 11! At least now, Irish backpackers will be welcome? Ireland can now look forward to wart free STD clinics in due course. Any chance of a job back home.......?
Posted by: Dr Colm O'Mahony on Wednesday 10 February 2010